Deals In Depth: March 2015
Executive Summary
Zogenix sold the Zohydro franchise to Pernix; AbbVie got its hands on Imbruvica through the $20 billion takeover of Pharmacyclics. Biopharma financing reached a six-month high in March, while in medtech the total was a six-month low.